Cargando…
Doxycycline-induced ulceration mimicking esophageal cancer
INTRODUCTION: Doxycycline-induced esophageal ulcer patients are mostly young persons with no history of esophageal dysfunction. Heartburn, midsternal pain and dysphagia are the most common symptoms. It has generally a benign course. The present case is the first report of doxycycline-induced extensi...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553052/ https://www.ncbi.nlm.nih.gov/pubmed/18778470 http://dx.doi.org/10.1186/1757-1626-1-144 |
_version_ | 1782159472782737408 |
---|---|
author | Tahan, Veysel Sayrak, Hakan Bayar, Nevzat Erer, Burak Tahan, Gulgun Dane, Faysal |
author_facet | Tahan, Veysel Sayrak, Hakan Bayar, Nevzat Erer, Burak Tahan, Gulgun Dane, Faysal |
author_sort | Tahan, Veysel |
collection | PubMed |
description | INTRODUCTION: Doxycycline-induced esophageal ulcer patients are mostly young persons with no history of esophageal dysfunction. Heartburn, midsternal pain and dysphagia are the most common symptoms. It has generally a benign course. The present case is the first report of doxycycline-induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments alongside, in the literature. CASE PRESENTATION: This report describes a 16-year-old Caucasian girl who, while taking doxycycline capsules100 mg twice a day for acne vulgaris for 3 months, developed these symptoms. An upper endoscopy revealed multiple circumferential deep ulcerations surrounding fragile, irregular, hyperemic and hypertrophic mucosa at the level of the mid-esophagus and concomitantly in the lower esophageal sphincter. The lesions were biopsied to exclude esophageal carcinoma because of the suspicious appearance in the endoscopic examination. The histopathological examination, haematoxylin and eosin stained sections showed ulceration with a mixed inflammatory infiltrate. Doxycycline was discontinued and she was given sucralfate 1 g qid and omeprazole 20 mg bid orally. All symptoms of the patient were resolved on the third day of the treatment. After 4 weeks of the therapy, an upper endoscopic control examination demonstrated normal findings. CONCLUSION: The present case has been an uncommon presentation of doxycycline-induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments, concomitantly. Even the lesions were biopsied to exclude esophageal carcinoma. A modification on the behavior of taking drugs can prevent these unpleasant complications. |
format | Text |
id | pubmed-2553052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25530522008-09-25 Doxycycline-induced ulceration mimicking esophageal cancer Tahan, Veysel Sayrak, Hakan Bayar, Nevzat Erer, Burak Tahan, Gulgun Dane, Faysal Cases J Case Report INTRODUCTION: Doxycycline-induced esophageal ulcer patients are mostly young persons with no history of esophageal dysfunction. Heartburn, midsternal pain and dysphagia are the most common symptoms. It has generally a benign course. The present case is the first report of doxycycline-induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments alongside, in the literature. CASE PRESENTATION: This report describes a 16-year-old Caucasian girl who, while taking doxycycline capsules100 mg twice a day for acne vulgaris for 3 months, developed these symptoms. An upper endoscopy revealed multiple circumferential deep ulcerations surrounding fragile, irregular, hyperemic and hypertrophic mucosa at the level of the mid-esophagus and concomitantly in the lower esophageal sphincter. The lesions were biopsied to exclude esophageal carcinoma because of the suspicious appearance in the endoscopic examination. The histopathological examination, haematoxylin and eosin stained sections showed ulceration with a mixed inflammatory infiltrate. Doxycycline was discontinued and she was given sucralfate 1 g qid and omeprazole 20 mg bid orally. All symptoms of the patient were resolved on the third day of the treatment. After 4 weeks of the therapy, an upper endoscopic control examination demonstrated normal findings. CONCLUSION: The present case has been an uncommon presentation of doxycycline-induced extensive ulcerations, mimicking esophageal cancer in two esophageal segments, concomitantly. Even the lesions were biopsied to exclude esophageal carcinoma. A modification on the behavior of taking drugs can prevent these unpleasant complications. BioMed Central 2008-09-08 /pmc/articles/PMC2553052/ /pubmed/18778470 http://dx.doi.org/10.1186/1757-1626-1-144 Text en Copyright © 2008 Tahan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Tahan, Veysel Sayrak, Hakan Bayar, Nevzat Erer, Burak Tahan, Gulgun Dane, Faysal Doxycycline-induced ulceration mimicking esophageal cancer |
title | Doxycycline-induced ulceration mimicking esophageal cancer |
title_full | Doxycycline-induced ulceration mimicking esophageal cancer |
title_fullStr | Doxycycline-induced ulceration mimicking esophageal cancer |
title_full_unstemmed | Doxycycline-induced ulceration mimicking esophageal cancer |
title_short | Doxycycline-induced ulceration mimicking esophageal cancer |
title_sort | doxycycline-induced ulceration mimicking esophageal cancer |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553052/ https://www.ncbi.nlm.nih.gov/pubmed/18778470 http://dx.doi.org/10.1186/1757-1626-1-144 |
work_keys_str_mv | AT tahanveysel doxycyclineinducedulcerationmimickingesophagealcancer AT sayrakhakan doxycyclineinducedulcerationmimickingesophagealcancer AT bayarnevzat doxycyclineinducedulcerationmimickingesophagealcancer AT ererburak doxycyclineinducedulcerationmimickingesophagealcancer AT tahangulgun doxycyclineinducedulcerationmimickingesophagealcancer AT danefaysal doxycyclineinducedulcerationmimickingesophagealcancer |